Amgen’s lupus efforts may be about to succeed. Daxdilimab, a monoclonal antibody acquired from Horizon Therapeutics in 2023, hit the primary endpoint in a phase 2...

Basilea Pharmaceutica is continuing its quest to develop much-needed new antifungal drugs by penning a deal with Prokaryotics.  The collaboration will see Switzerland-based Basilea and...

Nanoform has announced that it has established, in collaboration with A.forall Development NV, a wholly owned subsidiary of Boston-based private equity company The Riverside...

ExpreS2ion Biotechnologies has selected Northway Biotech as its cGMP contract development and manufacturing organisation (CDMO) for its Nipah virus vaccine candidate. The programme is being...

AstraZeneca has strengthened its weight management portfolio through a new strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of multiple next-generation therapies...

GSK’s potential ‘functional cure’ for hepatitis B drug has performed strongly in a pair of hotly anticipated phase 3 studies, setting up the pharma for...

Pulmocide’s phase 3 trial has been cancelled after patients who received its investigational inhaled antifungal had lower response rates and a higher number of...

A phase 3 trial of Hutchmed’s autoimmune disease candidate sovleplenib has hit ts primary endpoint, delivering a boost to an asset that was held...

Corxel Pharmaceuticals has announced the successful completion of its Series D1 financing, raising up to $287 million in capital. Proceeds from the round are expected...

Pentixapharm Holding AG, an advanced clinical-stage biotech developing novel radiopharmaceuticals, presented extensive clinical data from independent investigator-initiated studies assessing Pentixapharm’s CXCR4-targeting diagnostic lead candidate,...

Johnson & Johnson has shaken-hands on a most-favoured-nation (MFN) drug pricing deal with the Trump administration. With the agreement—which frees J&J up from tariffs on...

ExpreS2ion Biotechnologies has selected Northway Biotech as its cGMP contract development and manufacturing organisation (CDMO) for its Nipah virus vaccine candidate. The programme is being...

Alexion, AstraZeneca Rare Disease, and Wolves Foundation have announced a new partnership to raise awareness of rare diseases and support the Foundation’s disability football...

Enzymatica is proud to announce a partnership with the Swedish Biathlon Federation, under which Enzymatica becomes an official supplier to the national federation. The collaboration focuses on initiatives...

Sanofi US announces a broad expansion of its Insulins Valyou Savings Program by offering a 30-day supply of any Sanofi insulin for $35 to all patients in...

Tempris, an innovation leader in wireless in-process product temperature control for freeze-drying, is delighted to announce that it has been presented with the 2025...

Terumo Corporation has announced the successful completion of its acquisition of a drug product plant and associated quality control laboratory operations from WuXi Biologics in...

SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, has announced the availability of validated automated...

ACD/Labs, an informatics company that develops and commercializes software in support of digitalised R&D, has announced the release of a new two-part white paper...

Sapio Sciences has announced the launch of the world’s first 3rd-generation Electronic Lab Notebook (ELN) that thinks like a scientist, Sapio ELaiN. Sapio ELaiN is an...

Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered a partnership with...

Samsung Biologics has announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100% of Human...

To answer the global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2, Natix has forged a strategic alliance with Deebio, a prominent Chinese manufacturer of...

Cold Chain Technologies (CCT), a global leader in temperature-controlled packaging, is transforming how specialty pharmacies manage cold chain logistics with its innovative digital applications...

Enzene has announced the initiation of commercial supply of pertuzumab, a monoclonal antibody (mAb) therapy indicated for the treatment of HER2-positive (HER2+) breast cancer....

ELRIG has announced the keynote speakers for Cell and Gene Therapy 2026. Drs Stephen Ward (Cell and Gene Therapy Catapult) and Annarita Miccio (Imagine...

CRISPR Therapeutics, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will...

Following a landmark gathering of over 2,200 life sciences supply chain leaders in April, LogiPharma’s 25th anniversary edition is being recognised not only for...

This year, the Hamburg based life sicences company Eppendorf SE awarded its prestigious research prize for the 30th time. The independent jury chaired by...

Inspiring the Future of Chemistry and Life Sciences, Ilmac celebrates its 66th year with a bold new format, world-class speakers, and a major anniversary...

Swedish biotech company AAX Biotech AB announces a collaboration with Daiichi Sankyo, one of the global leaders in antibody-drug conjugates (ADCs), to investigate the...

Formation Bio has acquired the worldwide rights, excluding Greater China, to FHND5032, an oral, small-molecule miR-124 activator being developed for the treatment of  autoimmune...

Rumours that Eli Lilly planned to buy Ventyx Biosciences have been confirmed. A report in the Wall Street Journal, has been proved correct as Lilly announced...

Global chipmaker giant NVIDIA kicked off JPM Week with several partnership announcements, most notably a billion-dollar partnership with Indianapolis-based Eli Lilly. The new deal builds...

Nanoform Finland plc, the medicine performance-enhancing company, has announced new midterm business targets for 2030. Nanoform’s priorities for its 2026-2030 strategy period are to have: Three...